Loading…
Alumis Inc. is projected to rise to $24.14 by 2027, a +13% move from its current price of $21.33. ALMS is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $20.62 | $21.33 | $22.06 | 0.00% |
| May 30 | $20.34 | $21.33 | $22.37 | 0.00% |
| May 31 | $20.12 | $21.33 | $22.62 | +0.01% |
| Jun 1 | $19.94 | $21.33 | $22.82 | +0.01% |
| Jun 2 | $19.78 | $21.33 | $23.01 | +0.01% |
| Jun 3 | $19.64 | $21.33 | $23.17 | +0.01% |
| Jun 4 | $19.51 | $21.33 | $23.33 | +0.01% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $19.51 | $21.33 | $23.33 | +0.01% |
| Week 2 | $18.80 | $21.34 | $24.21 | +0.02% |
| Week 3 | $18.28 | $21.34 | $24.91 | +0.04% |
| Week 4 | $17.85 | $21.34 | $25.52 | +0.05% |
| Week 5 | $17.48 | $21.34 | $26.06 | +0.06% |
| Week 6 | $17.15 | $21.35 | $26.57 | +0.07% |
| Week 7 | $16.85 | $21.35 | $27.04 | +0.08% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Alumis Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of medicines for autoimmune disorders. The company offers envudeucitinib, a tyrosine kinase 2 (TYK2) inhibitor for the treatment of plaque psoriasis and systemic lupus erythematosus; and A-005, a central nervous system-penetrant allosteric TYK2 inhibitor that is in Phase 1 for the treatment of neuroinflammatory and neurodegenerative diseases.
It also develops lonigutamab, a monoclonal antibody targeting IGF-1R for the treatment of thyroid eye diseases; and IRF5 to address immune dysfunction. The company was formerly known as Esker Therapeutics, Inc. and changed its name to Alumis Inc.
in January 2022. Alumis Inc. was incorporated in 2021 and is headquartered in South San Francisco, California.
Alumis Inc. (ALMS) trades with a current price of $22.02 and a market capitalization of $2.81B. The company holds a rank of 1774. The near-term price outlook reflects a cautious stance with a neutral to bullish trajectory over the forecast horizon, supported by a defined 30-day range and technical levels.
The stock’s current price aligns with the 2026 forecast average, while longer-horizon projections show substantial upside.
A major floor 16.1% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.8% away) — a key level to hold.
The nearest ceiling, 22.5% above — a clean break opens room to run.
A major ceiling 40.6% above — clearing it would confirm fresh momentum.
Key ALMS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ALMS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $21.98 | Sell | $21.94 | Sell |
| MA 10 | $22.49 | Sell | $22.40 | Sell |
| MA 20 | $23.46 | Sell | $23.04 | Sell |
| MA 50 | $23.79 | Sell | $23.59 | Sell |
| MA 100 | $24.48 | Sell | $21.94 | Sell |
| MA 200 | $15.27 | Buy | $17.82 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 38.84 | Neutral |
| Stoch RSI (14) | 16.27 | Buy |
| CCI (20) | -110.87 | Sell |
| Williams %R (14) | -95.15 | Info |
| MACD (12,26,9) | -0.22 | Sell |
| ROC (12) | -9.85 | Sell |
| Bollinger %B (20,2) | 0.14 | Neutral |
| Stochastic %K (14) | 4.85 | Buy |
| TRIX (15) | -0.28 | Sell |
| Awesome (5,34) | -1.84 | Sell |
| Ultimate (7,14,28) | 31.82 | Neutral |
| Momentum (10) | -2.18 | Sell |
| Aroon Osc (25) | -36.00 | Sell |
| Hull MA (9) | 21.88 | Sell |
| ADX (14) | 13.53 | Neutral |
| ATR (14) | 0.68 | Info |
The 30-day technical picture is neutral, with RSI(14) at 40. Price action is hovering near the SMA50 of $23.94 and above the SMA200 of $15.10, suggesting mixed short-term momentum. Support sits at $21.15 and resistance at $26.13, framing a near-term trading band.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $8.31 | $21.33 | $29.52 | 0% | Neutral | |
| $18.71 | $24.14 | $33.26 | +13% | Neutral | |
| $22.35 | $29.85 | $42.91 | +40% | Bullish | |
| $26.90 | $36.99 | $54.99 | +73% | Bullish | |
| $25.66 | $36.22 | $55.38 | +70% | Bullish | |
| $25.60 | $37.00 | $57.99 | +73% | Bullish | |
| $26.77 | $39.57 | $63.40 | +86% | Bullish | |
| $25.88 | $39.06 | $63.85 | +83% | Bullish | |
| $32.30 | $49.75 | $82.82 | +133% | Bullish | |
| $36.80 | $57.80 | $97.88 | +171% | Bullish | |
| $41.56 | $71.38 | $129.75 | +235% | Bullish | |
| $73.86 | $148.76 | $299.57 | +597% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $8.31 | $21.33 | $25.03 | +0.00% |
| June 2026 | $17.54 | $20.70 | $25.10 | -2.94% |
| July 2026 | $17.91 | $21.36 | $26.33 | +3.19% |
| August 2026 | $18.61 | $22.38 | $27.93 | +4.75% |
| September 2026 | $18.33 | $22.20 | $27.99 | -0.81% |
| October 2026 | $18.12 | $22.08 | $28.11 | -0.51% |
| November 2026 | $18.67 | $22.87 | $29.35 | +3.58% |
| December 2026 | $18.53 | $22.83 | $29.52 | -0.19% |
Click any year to see its month-by-month ALMS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Alumis Inc.'s 2026 outlook centres on $21.33, within a $8.31 to $29.52 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, ALMS could reach as high as $33.26, with a base case around $24.14 and support toward $18.71 — roughly +13% from $21.33. A consolidation phase looks the most probable path here.
Expect ALMS to range from $22.35 to $42.91 through 2028. The $29.85 average target implies a +40% move from current prices. That is up +24% on the projected 2027 average. Momentum favours further upside here.
The ALMS price prediction for 2029 points to an average of $36.99 (low $26.90, high $54.99) — a potential gain of +73% on today's $21.33. Buyers look set to stay in control over this stretch.
In 2030, ALMS is projected to trade between $25.66 and $55.38, averaging $36.22 — a potential gain of +70% from today's $21.33. That is -2% versus the projected 2029 average. Momentum favours further upside here.
Alumis Inc.'s 2031 outlook centres on $37.00, within a $25.60 to $57.99 range. That is up +2% on the projected 2030 average. That marks a +73% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, ALMS could reach as high as $63.40, with a base case around $39.57 and support toward $26.77 — roughly +86% from $21.33. Momentum favours further upside here.
Expect ALMS to range from $25.88 to $63.85 through 2033. The $39.06 average target implies a +83% move from current prices. That is -1% versus the projected 2032 average. Buyers look set to stay in control over this stretch.
The ALMS price prediction for 2034 points to an average of $49.75 (low $32.30, high $82.82) — a potential gain of +133% on today's $21.33. Momentum favours further upside here.
In 2035, ALMS is projected to trade between $36.80 and $97.88, averaging $57.80 — a potential gain of +171% from today's $21.33. That is up +16% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Alumis Inc.'s 2040 outlook centres on $71.38, within a $41.56 to $129.75 range. That is up +23% on the projected 2035 average. That marks a +235% change versus current levels. Momentum favours further upside here.
By 2050, ALMS could reach as high as $299.57, with a base case around $148.76 and support toward $73.86 — roughly +597% from $21.33. Buyers look set to stay in control over this stretch.
Investing $1,000 in ALMS today (≈ 46.882325 ALMS) could be worth
$6,974.28
+$5,974.28 (+597%) by 2050 · US Dollar
Based on the average projected ALMS price of $148.76 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ALMSwould be worth at today's price.
$1,000 invested in ALMS on May 27, 2025 (≈ 224.719111 ALMS) would be worth
$4,793.26
+$3,793.26 (+379.3%) today · 4.79× · US Dollar
Based on a ALMS entry price of $4.45 vs. today's $21.33.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $22.04 | $967.79 | -3.2% |
| 1 month ago | $24.75 | $861.82 | -13.8% |
| 3 months ago | $29.98 | $711.47 | -28.9% |
| 6 months ago | $7.67 | $2,780.96 | +178.1% |
| 1 year ago | $4.45 | $4,793.26 | +379.3% |
| All time (1.9y) ago | $13.3 | $1,603.76 | +60.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ALMS forecast.
Our base-case forecast reaches $43.00 around 2034.
Implied market cap at $43.00: $5.31B
The multi-year forecast shows a transition from neutral in 2026–2027 to bullish thereafter. The 2026 average is $22.02 with a 0% ROI, then 2027 at $25.99 with 18% ROI. Beginning in 2028 the outlook strengthens with a 2028 average of $32.89 (49.4% ROI) and 2029 average of $40.42 (83.5% ROI).
The trend continues through 2030 at an average of $39.89 (81.2% ROI) and 2031 at $41.24 (87.3% ROI). By 2032 the average is $44.28 (101.1% ROI) and 2033 at $44.63 (102.7% ROI). The 2034–2035 period shows notable gains, with 2034 average $58.08 (163.8% ROI) and 2035 average $66.77 (203.2% ROI).
The forecast extends to 2040 with an average of $86.04 (290.7% ROI) and to 2050 with an average of $177.30 (705.2% ROI). The sentiment shifts to BULLISH from 2028 onward, culminating in substantial upside by mid-century and beyond.
Tap a question to reveal the answer.
2030: min $28.13, avg $39.89, max $61.30; ROI 81.2%; sentiment BULLISH.
The forecast shows NEUTRAL in 2026 and 2027, then BULLISH from 2028 onward, with the 2026 avg at $22.02 and rising to higher levels (e.g., 2030 avg $39.89). Max forecasts extend to $360.01 by 2050; these are estimates, not guarantees.
Yes. The 2035 max is $113.77, the 2040 max is $157.52, and the 2050 max is $360.01, indicating potential to move above $100 in the forecast horizon.
Current price $22.02; Market cap $2.81B.
30-day range: low $17.55, high $27.63.
Alumis Inc. Community Discussion
0Share your Alumis Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.